HIV Disclosure and Transmission Risks to Sex Partners Among HIV-Positive Men
- 1 May 2016
- journal article
- research article
- Published by SAGE Publications in AIDS Patient Care and STDs
- Vol. 30 (5) , 221-228
Abstract
Disclosure of HIV-positive status to sex partners is critical to protecting uninfected partners. In addition, people living with HIV often risk criminal prosecution when they do not inform sex partners of their HIV status. The current study examined factors associated with nondisclosure of HIV status by men living with HIV in Atlanta, GA (92% African African, mean age = 43.8), who engage in condomless sex with uninfected sex partners. Sexually active HIV-positive men (N = 538) completed daily electronic sexual behavior assessments over the course of 28 days and completed computerized interviews, drug testing, medication adherence assessments, and HIV viral load retrieved from medical records. Results showed that 166 (30%) men had engaged in condomless vaginal or anal intercourse with an HIV-uninfected or unknown HIV status sex partner to whom they had not disclosed their HIV status. Men who engaged in nondisclosed condomless sex were less adherent to their HIV treatment, more likely to have unsuppressed HIV, demonstrated poorer disclosure self-efficacy, enacted fewer risk reduction communication skills, and held more beliefs that people with HIV are less infectious when treated with antiretroviral therapy. We conclude that undisclosed HIV status is common and related to condomless sex with uninfected partners. Men who engage in nondisclosed condomless sex may also be more infectious given their nonadherence and viral load. Interventions are needed in HIV treatment as prevention contexts that attend to disclosure laws and enhance disclosure self-efficacy, improve risk reduction communication skills, and increase understanding of HIV infectiousness.Keywords
This publication has 41 references indexed in Scilit:
- Adherence Profiles and Therapeutic Responses of Treatment-Naive HIV-Infected Patients Starting Boosted Atazanavir-Based Therapy in the ANRS 134-COPHAR 3 TrialAntimicrobial Agents and Chemotherapy, 2013
- Trends in Ambulatory Self-ReportPsychosomatic Medicine, 2012
- HIV-1 low-level viraemia assessed with 3 commercial real-time PCR assays show high variabilityBMC Infectious Diseases, 2012
- Serostatus Disclosure Among Adults with HIV in the Era of HIV TherapyAIDS Patient Care and STDs, 2012
- Social Network Predictors of Disclosure of MSM Behavior and HIV-Positive Serostatus Among African American MSM in Baltimore, MarylandAIDS and Behavior, 2011
- Sexually transmitted infections and infectiousness beliefs among people living with HIV/AIDS: implications for HIV treatment as preventionHIV Medicine, 2010
- Adherence to Antiretroviral Therapy Assessed by Unannounced Pill Counts Conducted by TelephoneJournal of General Internal Medicine, 2007
- Reducing HIV Transmission Risk by Increasing Serostatus Disclosure: A Mathematical Modeling AnalysisAIDS and Behavior, 2006
- Accuracy of Audio Computer-Assisted Self-Interviewing (ACASI) and Self-Administered Questionnaires for the Assessment of Sexual BehaviorAIDS and Behavior, 2006
- The CES-D ScaleApplied Psychological Measurement, 1977